Operating profit before deduction of amortization: XORTX Therapeutics (XRTX)
Niche concentration on renal pathology therapies creates a significant binary risk for XORTX Therapeutics Inc. (XRTX). Internal potential is based on large-scale R&D investments in xanthine oxidase inhibitors. The absence of recurring revenue makes the company dependent on external capital, which is confirmed by the operating cash flow volume, where 0.00 represents the latest metric reading.
xortx.com (XRTX) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio XORTX Therapeutics Inc.|XRTX - Long-Term Debt to Capital|Current Liabilities to Capital XORTX Therapeutics Inc.|XRTX - Company Total Debt|Debt to Book Value Ratio XORTX Therapeutics Inc|XRTX - Company Long-Term Debt|Short-Term Debt XORTX Therapeutics|Intermediate Coverage Ratio xortx.com
- earnings and multiples data:
XRTX - Net Income|Future Net Profit XORTX Therapeutics Inc.|XRTX - Price to Earnings Ratio|Price to Future Earnings Ratio XORTX|XRTX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation XORTX|XRTX - Operating profit before deduction of amortization|Earnings per share for the last four quarters XORTX Therapeutics|XRTX - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months xortx.com|XRTX - Earnings growth in current year|Expected net earnings per share growth next year XORTX Therapeutics Inc.
- sales and revenue indicators:
Fundamental company valuation:xortx.com - XRTX
For XORTX Therapeutics Inc. (XRTX), which is awaiting Phase 2 clinical trial results, this metric reflects the actual cash efficiency of assets excluding accounting depreciation. Analyzing the operating cash flow allows for an assessment of the business's ability to generate liquidity amidst regulatory risks, where a narrowing of the curve's amplitude signals a critical funding shortage and a threat of investment impairment.
Competitors of XORTX Therapeutics Inc. (XRTX)
Operating income before deduction of amortization argenx.com (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax Corp (ABVX) - Operating profit before deduction of amortization|ADMA Corp (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics|Operating profit before deduction of amortization IMVT|Operating profit EBITDA kiniksa.com|Profit before payment of interest, taxes and amortization Grifols Group (GRFS)|Adaptive Biotechnologies Corporation - Operating profit before amortization|Operating profit EBITDA CLDX (celldex.com)|Aurinia Pharma (AUPH) - Profit before interest, taxes and amortization|BioCryst - Operating profit EBITDA|VERA: Profit before payment of interest, taxes and amortization|DNTH: Operating profit EBITDA|Pharvaris - Income before deduction of interest, taxes and amortization|ABCL (AbCellera Bio) - Operating profit EBITDA|Operating profit EBITDA Tourmaline|Operating profit EBITDA PGEN|PHAR (pharming.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (nektar.com)|Upstream Bio (UPB) - Profit before interest, taxes and amortization|ZBIO: Operating profit before deduction of amortization|Profit before interest, taxes and amortization Immunome Bio|GOSS: Operating profit EBITDA|KALV: Company profit before taxes, interest and amortization|SEPN (septerna.com) - Operating profit EBITDA|Pieris Pharmaceuticals, Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Savara Inc. (SVRA)|Operating profit EBITDA Rigel Corp (RIGL)|Profit before payment of interest, taxes and amortization AnaptysBio Inc ANAB|astriatx.com (ATXS) - Profit before interest, taxes and amortization|enGene Bio - Operating profit EBITDA|Profit before deduction of interest, taxes, depreciation and amortization RAPT|JBIO: Operating profit EBITDA|Aclaris - Income before deduction of interest, taxes and amortization|KYTX (Kyverna Therapeutics, Inc) - Operating profit EBITDA|TLSA: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization CABA (Cabaletta Bio)|VTYX - Profit before interest, taxes and amortization|Operating profit EBITDA THTX (Theratechnologies, Inc)|Company profit before taxes, interest and amortization AVTX (Avalo Therapeutics Inc.)|ELDN: Operating profit before deduction of amortization|AGEN - Operating profit EBITDA|Climb Bio Inc. (CLYM) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ZURA (Zura Bio)|Operating profit before deduction of amortization ATYR|ADAG: Income before deduction of interest, taxes and amortization|Operating profit EBITDA IMA|Operating income before deduction of amortization Shattuck Therapeutics|Operating profit EBITDA EQ (Equillium Inc)|Company profit before taxes, interest and amortization CNTB (Connect Pharma)|IMUX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization atarabio.com ATRA|IFRX: Operating profit EBITDA|XFOR (X4 Pharmaceuticals, Inc) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization adicetbio.com|CELU: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization INmune Bio Corporation (INMB)|Operating profit before deduction of amortization Barinthus Biotherapeutics Corp BRNS|Profit before payment of interest, taxes and amortization Kezar Life Sciences KZR|Income before deduction of interest, taxes and amortization SABS|AKTX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization ENLV (enlivex.com)|Q32 Bio Inc. (QTTB) - Profit before payment of interest, taxes and amortization|GeoVax Labs Inc - Income before deduction of interest, taxes and amortization|EDSA (Edesa Biotech Corp) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization IBIO|Profit before payment of interest, taxes and amortization Carisma Therapeutics Inc (CARM)|Operating profit EBITDA XTL Biopharmaceuticals Ltd (XTLB)|Operating profit EBITDA BOLT (Bolt Biotherapeutics Inc.)|Operating income before deduction of amortization HCW Biologics Inc. (HCWB)|Aptevo Therapeutics, Inc. - Operating profit EBITDA|Operating income before deduction of amortization aimimmuno.com AIM|ADTX (aditxt.com) - Operating profit before deduction of amortization|GRI (GRI Bio) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization HIND|REVB: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization indaptusrx.com (INDP)|Operating profit before deduction of amortization Scinai Immunotherapeutics SCNI|Operating profit EBITDA CALI (CalciMedica Inc)|AFMD: Operating profit before amortization|ALLK - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization hookipapharma.com|IGMS: Operating profit EBITDA|ITOS: Company profit before taxes, interest and amortization|OCEA (Ocean Biomedical Corp) - Operating profit EBITDA|TCBP: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Third Harmonic Bio, Inc (THRD)
